INVESTORS & MEDIA

Jul 17, 2019

Positive Top-Line Data from Phase IIb Study Evaluating TLPLDC

Jun 26, 2019

Elios Therapeutics Announces Appointment of Phillip Johnson as Chief Financial Officer

Jan 4, 2019

Perseus Holdings USA Appoints Veteran Biotechnology Executive William C. Pearson to BOD

Jun 1, 2018

Interim Phase IIb Results of TLPLDC, a Personalized Therapeutic Cancer Vaccine

Apr 17, 2018

Initial Phase 2b Results of TLPLDC, a Personalized Therapeutic Cancer Vaccine...

We would love to hear from you. Tell us a little about yourself and we will reach out.

Elios Therapeutics, LLC
111 Smith Hines Road, Suite E

Greenville, SC 29607